| dc.creator |
OKSAY, Taylan |
|
| dc.creator |
YUNUSOGLU, Sedat |
|
| dc.creator |
CALAPOĞLU, Mustafa |
|
| dc.creator |
CANDAN, I. Aydin |
|
| dc.creator |
Ergun, Osman |
|
| dc.creator |
ÖZORAK, Alper |
|
| dc.creator |
ONARAN, İbrahim |
|
| dc.date |
2017-04-30T21:00:00Z |
|
| dc.date.accessioned |
2020-10-06T10:25:38Z |
|
| dc.date.available |
2020-10-06T10:25:38Z |
|
| dc.identifier |
66bb55e7-85ae-4735-b737-a268bdfcf067 |
|
| dc.identifier |
10.1007/s11255-017-1534-x |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/66bb55e7-85ae-4735-b737-a268bdfcf067/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/62183 |
|
| dc.description |
Resveratrol (RES) is a polyphenol with antioxidant, anti-inflammatory, and many other physiological effects on tissues. In the present study, the effect of resveratrol in hyperoxaluria driven nephrolithiasis/nephrocalcinosis is investigated. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Protective impact of resveratrol in experimental rat model of hyperoxaluria |
|
| dc.type |
info:eu-repo/semantics/article |
|